Key facts
- Signals
- derived-health-indices
- Subjects
- 86
- License
- CC BY 4.0
Summary
Zenodo v2.0 (published 2026-10-09; Tognetti, Laurino et al.; EU HORIZON TOLIFE, GA 101057103). 86 COPD patients across Germany, Spain and Italy followed 12 months (enrolled May 2024 to Sep 2025; monitoring May 2024 to Apr 2026) with the TOLIFE sensor kit (commercial devices incl. smartphone and smartwatch), with periodic clinical exams as reference.